Back to Search
Start Over
Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
- Source :
-
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 1998 Oct 01; Vol. 161 (7), pp. 3464-8. - Publication Year :
- 1998
-
Abstract
- Induction of the alpha-platelet-derived growth factor receptor (PDGF-Ralpha) by IL-1beta in lung myofibroblasts enhances mitogenic and chemotactic responses to PDGF, and this could be a mechanism of myofibroblast hyperplasia during lung fibrogenesis. Since the regulation of many genes by IL-1beta involves activation of NF-kappaB and mitogen-activated protein (MAP) kinases, we examined these signaling pathways in the control of PDGF-Ralpha expression by IL-1beta in cultured rat lung myofibroblasts. Treatment of cells with pyrrolidine dithiocarbamate (PDTC), an antioxidant that inhibits NF-kappaB activation, completely blocked PDGF-Ralpha up-regulation by IL-1beta as assayed by [125I]PDGF-AA binding and PDGF-Ralpha mRNA expression, suggesting a role for NF-kappaB. However, while IL-1beta and TNF-alpha both induced nuclear binding of the Rel proteins p50 and p65 to an NF-kappaB consensus oligonucleotide in gel shift assays and caused transient degradation of inhibitor of NF-kappaB-alpha (IkappaB-alpha) in the cytoplasm of myofibroblasts, only IL-1beta upregulated PDGF-Ralpha. These results suggest that NF-kappaB activation alone is not sufficient for up-regulation of PDGF-Ralpha. An investigation of MAP kinase signaling pathways revealed that IL-1beta or PDTC activated extracellular signal-regulated kinase-2 (ERK-2) and c-jun NH2 terminal kinase-1 (JNK-1) phosphorylation of PHAS-1 and c-Jun substrates, respectively. Pretreatment of cells with the MAP kinase kinase-1 (MEK1) inhibitor PD 98059 blocked IL-1beta-induced activation of ERK-2 by more than 90% but enhanced IL-1beta-stimulated induction of PDGF-Ralpha expression fourfold. Taken together, these data suggest that IL-1beta activates both positive and negative signaling pathways that control the expression of PDGF-Ralpha. IL-1beta appears to mediate its negative effects on PDGF-Ralpha expression via MAP kinase activation, while the factor(s) that mediate induction of PDGF-Ralpha remain to be elucidated.
- Subjects :
- Animals
Calcium-Calmodulin-Dependent Protein Kinases metabolism
Cells, Cultured
Enzyme Activation drug effects
Enzyme Activation immunology
Fibroblasts enzymology
Fibroblasts metabolism
Flavonoids pharmacology
JNK Mitogen-Activated Protein Kinases
Lung enzymology
MAP Kinase Kinase 1
Mitogen-Activated Protein Kinase 1 antagonists & inhibitors
Mitogen-Activated Protein Kinase 1 metabolism
NF-kappa B antagonists & inhibitors
NF-kappa B metabolism
Protein Binding drug effects
Protein Binding immunology
Protein Serine-Threonine Kinases antagonists & inhibitors
Protein-Tyrosine Kinases antagonists & inhibitors
Pyrrolidines pharmacology
Rats
Receptor, Platelet-Derived Growth Factor alpha
Receptors, Platelet-Derived Growth Factor antagonists & inhibitors
Receptors, Platelet-Derived Growth Factor drug effects
Thiocarbamates pharmacology
Tumor Necrosis Factor-alpha pharmacology
Up-Regulation drug effects
Up-Regulation immunology
Calcium-Calmodulin-Dependent Protein Kinases physiology
Interleukin-1 pharmacology
Lung metabolism
Mitogen-Activated Protein Kinase Kinases
Mitogen-Activated Protein Kinases
NF-kappa B physiology
Receptors, Platelet-Derived Growth Factor biosynthesis
Signal Transduction immunology
Subjects
Details
- Language :
- English
- ISSN :
- 0022-1767
- Volume :
- 161
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Journal of immunology (Baltimore, Md. : 1950)
- Publication Type :
- Academic Journal
- Accession number :
- 9759865